Publication

From the pages of AllergyWatch December 2021

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Stanley Fineman, Emory UniversityGerald Lee, Emory UniversityVivian Hernandez-Trujillo, Allergy and Immunology Care Center of South FloridaShyam Joshi, Oregon Health and Science University
Language
  • English
Date
  • 2021-11-23
Publisher
  • ELSEVIER SCIENCE INC
Publication Version
Copyright Statement
  • © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 127
Issue
  • 6
Start Page
  • 705
End Page
  • 706
Grant/Funding Information
  • The authors have no funding sources to report.
Abstract
  • In patients with mastocytosis, vaccination has been reported to cause exacerbation of symptoms of mast cell (MC) activation, including anaphylaxis. Anaphylactic reactions to the Pfizer-BioNTech messenger RNA (mRNA) COVID-19 vaccine have been reported. An approach to the safe administration of COVID-19 mRNA vaccine in 2 patients with mastocytosis and MC activation symptoms is described.
Author Notes
  • Dr Fineman reports serving as a clinical investigator for Aimmune, DBV, Biocryst, and Regeneron, and as a speaker for Takeda. Dr Joshi reports serving on an advisory board for GlaxoSmithKline and as a speaker/teacher at PRIME Education, LLC. Dr Hernandez-Trujillo reports serving as consultant/advisor and received research funding from CSL Behring, and also received honoraria from Bayer, Meda, and Merck.
Keywords
Research Categories
  • Health Sciences, Immunology

Tools

Relations

In Collection:

Items

Thumbnail Title File Description Date Uploaded Visibility Actions
file details Publication File - w0xn9.pdf Primary Content 2025-05-13 Public Download